Extravasation Injury

• Extravasation Injury occurs when IV fluids or medications leak out of a vein into nearby tissues.
• It can be caused by fragile veins, improper needle placement, or patient movement.
• Common symptoms include pain, swelling, redness, and in severe cases, blistering or tissue necrosis.
• Immediate action, such as stopping the infusion and applying specific treatments, is crucial for managing the injury.
• The severity of the injury depends on the type of medication, the amount extravasated, and the speed of intervention.

What is Extravasation Injury?

Extravasation Injury refers to the inadvertent leakage of intravenously administered fluid or medication from a blood vessel into the perivascular or subcutaneous tissue. This complication is particularly concerning when vesicant drugs, which are agents capable of causing blistering, severe tissue damage, and necrosis, are involved. While any IV infusion can lead to extravasation, the potential for harm is significantly higher with certain medications, such as chemotherapy agents, vasopressors, and hyperosmolar solutions. The extent of the injury depends on several factors, including the type and concentration of the extravasated substance, the volume leaked, the location of the extravasation, and the duration of exposure.

The incidence of extravasation varies, with clinical studies indicating rates ranging from approximately 0.1% to 6% for peripheral intravenous infusions. However, for vesicant chemotherapy agents, the incidence can be higher, sometimes reaching up to 23% in specific patient populations, underscoring the critical need for careful administration and vigilant monitoring during IV therapy.

Causes and Symptoms of Extravasation Injury

The causes of extravasation injury are multifaceted, often stemming from a combination of patient-related factors, medication characteristics, and administration techniques. Common causes include fragile veins, which are prevalent in elderly or immunocompromised patients, and veins that are difficult to access. Improper venipuncture technique, such as piercing through the vein wall or inserting the needle at an incorrect angle, can also lead to leakage. Patient movement during infusion, especially in restless or uncooperative individuals, can dislodge the catheter. Furthermore, the properties of the medication itself, particularly its pH, osmolality, and vesicant potential, play a crucial role in determining the likelihood and severity of an extravasation event.

Recognizing extravasation injury symptoms promptly is vital for effective management and minimizing tissue damage. The signs and symptoms can vary but typically include:

• Pain or burning sensation: Often the first indicator, felt at or near the insertion site.
• Swelling: Visible puffiness around the IV site as fluid accumulates in the tissue.
• Redness or discoloration: Erythema or changes in skin color in the affected area.
• Blanching: Paleness of the skin around the site, especially with vasoconstrictive agents.
• Coolness or warmth: The affected area may feel cooler or warmer than surrounding skin.
• Absence of blood return: When attempting to aspirate from the IV catheter.
• Blistering or skin breakdown: In more severe cases, particularly with vesicant drugs, leading to potential tissue necrosis.

Healthcare professionals must be vigilant for these signs and symptoms throughout the infusion process to ensure timely intervention.

Extravasation Injury Treatment

Effective extravasation injury treatment relies on immediate recognition and prompt action to mitigate tissue damage. The first and most critical step is to immediately stop the infusion upon suspicion of extravasation. The healthcare provider should then attempt to aspirate any remaining drug from the IV catheter before carefully removing it. Depending on the type of extravasated substance, specific interventions are then employed. For many irritant solutions, elevating the affected limb and applying either warm or cold compresses may be recommended. Cold compresses are generally used for vesicant drugs to localize the agent and reduce absorption, while warm compresses are often preferred for non-vesicant irritants to promote vasodilation and dispersion.

For certain vesicant medications, specific antidotes may be injected into the extravasated area to neutralize or disperse the drug. For instance, hyaluronidase is commonly used for vinca alkaloids and other non-DNA binding vesicants to facilitate drug dispersion and absorption. Phentolamine may be used for adrenergic vasoconstrictors to counteract their effects. In severe cases where tissue necrosis is extensive, surgical intervention, such as debridement or skin grafting, may be necessary to remove damaged tissue and promote healing. Close monitoring of the injury site for signs of infection or worsening tissue damage is essential throughout the recovery period.